Last reviewed · How we verify

Staphylococcal infectious disease — Treatment Landscape & Competitive Intelligence

Staphylococcal infectious disease (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Staphylococcal infectious disease, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Bactocill In Plastic Container OXACILLIN Apothecon Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2 1971-01-01
Nallpen In Plastic Container NAFCILLIN SODIUM Pfizer Penicillin-class Antibacterial 1965-01-01
Nallpen In Plastic Container NAFCILLIN Pfizer Penicillin-class Antibacterial 1965-01-01
Lincocin LINCOMYCIN Pfizer lincomycin 1964-01-01
Vancocin vancomycin ANI Pharmaceuticals Alpha-2A adrenergic receptor, D-alanyl-D-alanine dipeptidase, UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. Pfizer · 3 drugs in Staphylococcal infectious disease
  2. · 1 drug in Staphylococcal infectious disease
  3. ANI Pharmaceuticals · 1 drug in Staphylococcal infectious disease
  4. Apothecon · 1 drug in Staphylococcal infectious disease

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Staphylococcal infectious disease:

Cite this brief

Drug Landscape (2026). Staphylococcal infectious disease — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/staphylococcal-infectious-disease. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing